These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 10393475)

  • 21. Actions of A-131701, a novel, selective antagonist for alpha-1A compared with alpha-1B adrenoceptors on intraurethral and blood pressure responses in conscious dogs and a pharmacodynamic assessment of in vivo prostatic selectivity.
    Hancock AA; Brune ME; Witte DG; Marsh KC; Katwala S; Milicic I; Ireland LM; Crowell D; Meyer MD; Kerwin JF
    J Pharmacol Exp Ther; 1998 May; 285(2):628-42. PubMed ID: 9580607
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antagonistic activity of tamsulosin against human vascular alpha1-adrenergic receptors.
    Harada K; Kawaguchi A; Ohmori M; Fujimura A
    Clin Pharmacol Ther; 2000 Apr; 67(4):405-12. PubMed ID: 10801250
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of tamsulosin on resting urethral pressure and arterial blood pressure in anaesthetized female dogs.
    Ohtake A; Sato S; Sasamata M; Miyata K
    J Pharm Pharmacol; 2006 Mar; 58(3):345-50. PubMed ID: 16536901
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quinazoline-derived alpha1-adrenoceptor antagonists induce prostate cancer cell apoptosis via an alpha1-adrenoceptor-independent action.
    Benning CM; Kyprianou N
    Cancer Res; 2002 Jan; 62(2):597-602. PubMed ID: 11809715
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Uroselectivity in male dogs of silodosin (KMD-3213), a novel drug for the obstructive component of benign prostatic hyperplasia.
    Tatemichi S; Tomiyama Y; Maruyama I; Kobayashi S; Kobayashi K; Maezawa A; Kobayashi M; Yamazaki Y; Shibata N
    Neurourol Urodyn; 2006; 25(7):792-9; discussion 800-1. PubMed ID: 16894620
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vivo study on the effects of alpha1-adrenoceptor antagonists on intraurethral pressure in the prostatic urethra and intraluminal pressure in the vas deferens in male dogs.
    Noguchi Y; Ohtake A; Suzuki M; Sasamata M
    Eur J Pharmacol; 2008 Feb; 580(1-2):256-61. PubMed ID: 18078926
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of tamsulosin on the resting tone and the contractile behaviour of the female urethra: a functional urodynamic study in healthy women.
    Reitz A; Haferkamp A; Kyburz T; Knapp PA; Wefer B; Schurch B
    Eur Urol; 2004 Aug; 46(2):235-40; discussion 240. PubMed ID: 15245819
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tamsulosin shows a higher unbound drug fraction in human prostate than in plasma: a basis for uroselectivity?
    Korstanje C; Krauwinkel W; van Doesum-Wolters FL
    Br J Clin Pharmacol; 2011 Aug; 72(2):218-25. PubMed ID: 21745239
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost-effectiveness of tamsulosin, doxazosin, and terazosin in the treatment of benign prostatic hyperplasia.
    Ohsfeldt RL; Kreder KJ; Klein RW; Chrischilles EA
    J Manag Care Pharm; 2004; 10(5):412-22. PubMed ID: 15369424
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An investigation of the uroselective properties of four novel alpha(1a)-adrenergic receptor subtype-selective antagonists.
    Pulito VL; Li X; Varga SS; Mulcahy LS; Clark KS; Halbert SA; Reitz AB; Murray WV; Jolliffe LK
    J Pharmacol Exp Ther; 2000 Jul; 294(1):224-9. PubMed ID: 10871316
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Doxazosin and terazosin suppress prostate growth by inducing apoptosis: clinical significance.
    Kyprianou N
    J Urol; 2003 Apr; 169(4):1520-5. PubMed ID: 12629407
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of alpha1-adrenoceptor antagonists in benign prostatic hyperplasia based on the receptor occupancy theory.
    Ito K; Ohtani H; Sawada Y
    Br J Clin Pharmacol; 2007 Apr; 63(4):394-403. PubMed ID: 17052252
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitation of in vitro α-1 adrenergic receptor antagonist binding capacity to biologic melanin using tandem mass spectrometry.
    Gaynes JS; Micic C; Gaynes BI; Borgia JA
    Curr Eye Res; 2013 Dec; 38(12):1214-20. PubMed ID: 24047464
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relative cytotoxic potencies and cell death mechanisms of α1 -adrenoceptor antagonists in prostate cancer cell lines.
    Forbes A; Anoopkumar-Dukie S; Chess-Williams R; McDermott C
    Prostate; 2016 Jun; 76(8):757-66. PubMed ID: 26880388
    [TBL] [Abstract][Full Text] [Related]  

  • 35. RBx 6198: a novel alpha1-adrenoceptor antagonist for the treatment of benign prostatic hyperplasia.
    Nanda K; Naruganahalli KS; Gupta S; Malhotra S; Tiwari A; Hegde LG; Jain S; Sinha N; Gupta JB; Chugh A; Anand N; Ray A
    Eur J Pharmacol; 2009 Apr; 607(1-3):213-9. PubMed ID: 19239913
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the cardiovascular effects of tamsulosin oral controlled absorption system (OCAS) and alfuzosin prolonged release (XL).
    Michel MC; Chapple CR
    Eur Urol; 2006 Mar; 49(3):501-8; discussion 508-9. PubMed ID: 16442211
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of tamsulosin, a novel alpha 1-adrenoceptor antagonist, on urethral pressure profile in anaesthetized dogs.
    Sudoh K; Tanaka H; Inagaki O; Asano M; Takenaka T
    J Auton Pharmacol; 1996 Jun; 16(3):147-54. PubMed ID: 8884461
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of the effect of mirodenafil on the hemodynamics of healthy male Korean volunteers administered tamsulosin: a randomized, double-blind, placebo-controlled, 2-period crossover study.
    Gu N; Kim J; Lim KS; Shin KH; Kim TE; Lee B; Shin SG; Jang IJ; Yu KS
    Clin Ther; 2012 Sep; 34(9):1929-39. PubMed ID: 22921287
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacological characterization of the uroselective alpha-1 antagonist Rec 15/2739 (SB 216469): role of the alpha-1L adrenoceptor in tissue selectivity, part I.
    Leonardi A; Hieble JP; Guarneri L; Naselsky DP; Poggesi E; Sironi G; Sulpizio AC; Testa R
    J Pharmacol Exp Ther; 1997 Jun; 281(3):1272-83. PubMed ID: 9190863
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical comparison of selective and non-selective alpha 1A-adrenoceptor antagonists for bladder outlet obstruction associated with benign prostatic hyperplasia: studies on tamsulosin and terazosin in Chinese patients. The Chinese Tamsulosin Study Group.
    Na YJ; Guo YL; Gu FL
    J Med; 1998; 29(5-6):289-304. PubMed ID: 10503165
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.